CAS vs Standard Technique in TKA: Comparison of Clinical and Functional Results (CAS-K)

September 19, 2025 updated by: Istituto Ortopedico Rizzoli

CAS vs Tecnica Chirurgica Standard Nella Protesi Totale di Ginocchio: Confronto Dei Risultati Clinico-funzionali

The study involves the enrollment of a sample of patients with indication for total knee replacement surgery in order to compare the conventional surgical technique currently used in the reference departments with the surgical technique with the aid of computer-assisted navigation.

The comparison between the two techniques will be performed in terms of clinical-functional results, perioperative bleeding and healthcare costs (surgical time, hospital stay).

The research protocol involves the participation of 160 total patients divided into two groups, of 80 patients each, by type of surgical technique.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bologna, Italy
        • Recruiting
        • Istituto Ortopedico Rizzoli
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with primary or secondary gonarthrosis with indication for knee arthroplasty with primary implant
  • Males and females aged ≥ 45
  • Willingness to participate in the study
  • Acquisition of informed consent to participate

Exclusion Criteria:

  • Patients who are not capable of understanding and willing, and therefore unable to express consent to participation in the study
  • Patient refusal to participate in the study and to sign the informed consent
  • Nickel allergy (suspected or diagnosed)
  • Pregnant women or women of childbearing age who cannot exclude pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: conventional total knee arthroplasty surgery
total knee arthroplasty performed with conventional technique
Experimental: computer-assisted total knee arthroplasty surgery
total knee arthroplasty performed with imageless computer-assisted surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Society Score (KSS)
Time Frame: From enrollment to 12 months post-operative followup

Knee Society Clinical Rating System (KSS):

there are 2 section, "Knee Score" section and a "Functional Score" section; both sections are scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions

From enrollment to 12 months post-operative followup
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: from enrollment to 12 months post-operative followup

Set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints.

The score measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68).

Higher scores indicate worse pain, stiffness, and functional limitations.

from enrollment to 12 months post-operative followup
NRS scale
Time Frame: from enrollment to 12 months post-operative followup

Numeric Pain Rating scale is a unidimensional measure of pain in which a patient selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.

0 = no pain, 10 = worst pain possible

from enrollment to 12 months post-operative followup

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surgical time
Time Frame: the day of surgical procedure
the day of surgical procedure
complications
Time Frame: from surgery to 12 month follow-up
using Clavien Dindo classification of surgical complications
from surgery to 12 month follow-up
delta hemoglobin
Time Frame: from surgery to discharge, up to 4 weeks
For each patient blood loss will be assessed by measuring the difference in hemoglobin (g/dL) on the preoperative blood sample VS last blood sample before discharge
from surgery to discharge, up to 4 weeks
Transfusions
Time Frame: from surgery to discharge, up to 4 weeks
It will be accounted the number of blood transfusions that patients may need during the hospital stay until discharge
from surgery to discharge, up to 4 weeks
hospital stay
Time Frame: from surgery to discharge, up to 4 weeks
days of hospital stay from surgery to discharge
from surgery to discharge, up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2024

Primary Completion (Estimated)

August 12, 2026

Study Completion (Estimated)

August 12, 2026

Study Registration Dates

First Submitted

September 10, 2024

First Submitted That Met QC Criteria

September 19, 2024

First Posted (Actual)

September 23, 2024

Study Record Updates

Last Update Posted (Actual)

September 22, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CE-AVEC 572/2023/Sper/IOR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthroplasty, Total

Clinical Trials on conventional total knee arthroplasty

Subscribe